跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 105 条关于
“pyrophosphate”
全部
105
临床试验
66
药物
25
机构
0
资讯
14
去年
PROPHECI Trial Launches to Test Pyrophosphate Treatment for Rare Calcification Disorder PXE
去年
BioMarin Acquires Inozyme Pharma for $270 Million, Adding Late-Stage Enzyme Therapy for Rare Genetic Disorder
11天前
Scientists Map the Enzymatic Route That Builds 5-Azacytidine in Nature, Revealing a Rare Skeletal-Editing Reaction
上个月
BioMarin to Acquire Alesta Therapeutics for ALE1, a Potential First Oral Therapy for Hypophosphatasia
去年
Inozyme's INZ-701 Shows Promise in ENPP1 Deficiency Trial with Sustained Phosphate Increases
2年前
Promontory Therapeutics Completes Enrollment in Phase 2 Trial of PT-112 for Late-Stage Metastatic Prostate Cancer
上个月
BioMarin acquires Alesta Therapeutics and its hypophosphatasia drug ALE1 in $275M deal
4个月前
BioMarin's BMN 401 Shows Mixed Results in Phase 3 Trial for Rare ENPP1 Deficiency
去年
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
9个月前
BioMarin Awaits Pivotal INZ-701 Trial Results Following $270M Inozyme Acquisition
第 1 页,共 2 页
上一页
下一页